ID   8E7 [Human B-cell P.aeruginosa LPS mAB producing]
AC   CVCL_6360
DR   CLO; CLO_0001522
DR   ATCC; CRL-8795
DR   BioSample; SAMN03472814
DR   Wikidata; Q54605601
RX   Patent=US4834975;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8795.
CC   Doubling time: ~24-36 hours (ATCC=CRL-8795).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa LPS Fisher immunotype 7.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8795
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 15,18
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   Patent=US4834975;
RA   Siadak A.W., Lostrom M.E.;
RT   "Human monoclonal antibodies to serotypic lipopolysaccharide
RT   determinants on Gram-negative bacteria and their production.";
RL   Patent number US4834975, 30-May-1989.
//